Ethan Phd Shen Purchases 3,100 Shares of YD Bio (NASDAQ:YDES) Stock

YD Bio Limited (NASDAQ:YDES) CEO Ethan Phd Shen acquired 3,100 shares of the company’s stock in a transaction that occurred on Wednesday, September 9th. The stock was bought at an average price of $3.93 per share, with a total value of $12,183.00. Following the transaction, the chief executive officer directly owned 11,245,631 shares in the company, valued at $44,195,329.83. The trade was a 0.03% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

YD Bio Stock Down 0.5%

YDES traded down $0.02 during mid-day trading on Thursday, reaching $3.90. The stock had a trading volume of 633,162 shares, compared to its average volume of 95,569. YD Bio Limited has a 52 week low of $1.70 and a 52 week high of $25.00. The firm’s fifty day simple moving average is $2.94 and its two-hundred day simple moving average is $4.55.

YD Bio (NASDAQ:YDES) last posted its quarterly earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.42 million during the quarter.

Hedge Funds Weigh In On YD Bio

A hedge fund recently raised its position in YD Bio stock. Geode Capital Management LLC raised its holdings in YD Bio Limited (NASDAQ:YDES) by 10.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 58,363 shares of the biotechnology company’s stock after acquiring an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.